Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
92
Figura humana en el arte
49
Historia y crítica
31
Indígenas de México
22
Crítica e interpretación
21
Biografías
17
Anatomía artística
16
Filosofía
14
Antigüedades
11
Dibujo
11
Literatura
9
Literatura española
8
Técnica
8
Política y gobierno
7
Español
6
Leyes y legislación
6
México
6
Poesía mexicana
6
Pruebas de inteligencia
6
pintura
6
Arte
5
Arte moderno
5
Aspectos sociales
5
Biografía
5
Ciencia
5
Ciencias sociales
5
Escultura
5
Figuras literarias
5
Música
5
Novela mexicana
5
-
34621por Kim, Seon Hee, Evans, Christopher H, Kim, Sunyoung, Oligino, Thomas, Ghivizzani, Steven C, Robbins, Paul D“…All mice had established disease at time of injection. As shown in Figure 1, the severity of arthritis (Fig. 1a), paw thickness (Fig. 1b), and the number of arthritic paws (Fig. 1c) were all significantly reduced in the Ad-mIL-4 group, compared with the saline- and Ad-eGFP-treated groups. …”
Publicado 2000
Enlace del recurso
Enlace del recurso
Texto -
34622por Joseph, Don R.“…In one instance, in which figures are given, the drug was administered in a five per cent. solution. …”
Publicado 1911
Enlace del recurso
Enlace del recurso
Texto -
34623por Ritter, Alison, Mellor, Richard, Chalmers, Jenny, Sunderland, Matthew, Lancaster, Kari“…RESULTS: Both need and demand are important estimates in planning for services but contain many difficulties in moving from the theory of measurement to the practicalities of establishing these figures. Furthermore, the simple quantum of need or demand is limited in its usefulness unless it is matched with consideration of different treatment types and their relative intensity, and/or explored as a function of geography and subpopulation. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
34624por Galvez, Carlos, Nizamuddin, Imran, Tuchman, Emily, Doukas, Peter, Reddy, Neha, Altman, Jessica K., Winter, Jane N., Gordon, Leo I., Barth, Dylan, Hodgins, Nicole, Pro, Barbara, Ma, Shuo, Dinner, Shira, Frankfurt, Olga, Mehta, Jayesh, Singhal, Seema, Adekola, Kehinde, Moreira, Jonathan, Tanna, Sajal D, Wehbe, Firas, Karmali, Reem“…Larger studies are needed to confirm our findings and help guide management of pts with hematologic malignancies during the SARS-CoV-2 pandemic. [Figure: see text] DISCLOSURES: Altman:Bristol-Myers Squibb: Consultancy; Janssen: Consultancy; Immune Pharmaceuticals: Consultancy; Syros: Consultancy; Genentech: Research Funding; Novartis: Consultancy; Amphivena: Research Funding; Amgen: Research Funding; Aprea: Research Funding; ImmunoGen: Research Funding; Celgene: Research Funding; Boehringer Ingelheim: Research Funding; Fujifilm: Research Funding; Kartos: Research Funding; AbbVie: Other: advisory board, Research Funding; Kura Oncology: Other: Scientific Advisory Board - no payment accepted, Research Funding; BioSight: Other: No payment but was reimbursed for travel , Research Funding; Daiichi Sankyo: Other: Advisory Board - no payment but was reimbursed for travel; Agios: Other: advisory board, Research Funding; Glycomimetics: Other: Data safety and monitoring committee; Astellas: Other: Advisory Board, Speaker (no payment), Steering Committee (no payment), Research Funding; Theradex: Other: Advisory Board; ASH: Consultancy; Cancer Expert Now: Consultancy; France Foundation: Consultancy; PeerView: Consultancy; PrIME Oncology: Consultancy. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
34625por Nadeem, Omar, Mo, Clifton C, Laubach, Jacob P., Bianchi, Giada, Redd, Robert, Barth, Peter, Bayliss, Trevor J., Sanchorawala, Vaishali, Shune, Leyla, Distaso, Alexandra, Dalton, Virginia, Sperling, Adam S, Amweg, Laura, McKenney, Mary, Colson, Kathleen, Millard, Ella L, Hou, Isabella, Savell, Alexandra, Masone, Kelly, Munshi, Nikhil C., Ghobrial, Irene M., Anderson, Kenneth, Richardson, Paul G.“…Updated data will be presented at the meeting. [Figure: see text] DISCLOSURES: Nadeem:Sanofi: Consultancy, Membership on an entity’s Board of Directors or advisory committees; Amgen: Membership on an entity’s Board of Directors or advisory committees; Adaptive: Membership on an entity’s Board of Directors or advisory committees; Janssen: Consultancy, Honoraria, Other: TRAVEL, ACCOMMODATIONS, EXPENSES; Celgene: Consultancy, Honoraria, Membership on an entity’s Board of Directors or advisory committees, Other: TRAVEL, ACCOMMODATIONS, EXPENSES; Takeda: Consultancy, Membership on an entity’s Board of Directors or advisory committees, Other: TRAVEL, ACCOMMODATIONS, EXPENSES. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
34626por Othman, Jad, Amer, Mariam, Amofa, Ruebina, Anderson, Laura, Austin, Michael J, Bashford, Alex, Belsham, Edward, Boot, Jesca, Campbell, Victoria Louise, Coats, Thomas, Collins, Angela, Crawley, Charles, Crolla, Francesca, Cross, Joe W, Dalley, Chris, Dang, Raymond, Dennis, Mike, Dhawan, Saniya, Elliott, Johnathon, Galli, Sofia, Gallipoli, Paolo, Hodgson, Katherine, Jain, Manish, Kalkur, Pallavi, Katsomitrou, Vana, Khan, Anjum, Khwaja, Asim, Krishnamurthy, Pramila, Latif, Annie, Laurie, John, Lim, Michael, Loizou, Eleana, Loke, Justin, Mannari, Deepak, Manson, Cara, Marshall, Scott R., Mobashwera, Behnaz, Murthy, Vidhya, Ochaya, Odong, Orthi, Shahzad, Palanicawandar, Renuka, Pillai, Srinivas, Radzova, Dominika, Rye, Adam, Saunders, Jamie, Smith, Matthew, Taussig, David, Taylor, Tom, Whitmill, Richard, Zhao, Rui, Freeman, Sylvie D, Craddock, Charles, Dillon, Richard“…The data support prospective comparisons of venetoclax-based regimens to IC in fit adults with AML particularly in older patients with de novo AML, NPM1-mutated and IDH-mutated disease. [Figure: see text] DISCLOSURES: Belsham: Celgene: Other: meeting attendance; Abbvie: Other: meeting attendance. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
34627por Pagnano, Katia B, Kok, Chung Hoow, Mauro, Michael J., Cortes, Jorge E., Evans, Nicola, Jiang, Qian, Milojkovic, Dragana, Moiraghi, Beatriz, Nicolini, Franck E., Ongondi, Matilda, Zackova, Daniela, Rea, Delphine, Hughes, Timothy P.“…Acknowledgment The iCMLf CANDID Study would not have been possible without the 186 physicians who contributed case reports. [Figure: see text] DISCLOSURES: Pagnano: Novartis: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Astellas: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Pintpharma: Other: Lecture; EMS: Other: Lecture; Jansenn: Other: Lecture. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
34628por Velasco, Pablo, Longo, Filomena, Piolatto, Andrea, Bardón-Cancho, Eduardo J., Ponce-Salas, Beatriz, Flevari, Pagona, Voskaridou, Ersi, Biemond, Bart J., Nur, Erfan, Delaporta, Polyxeni, Besse-Hammer, Tatiana, Ruiz-Llobet, Anna, Raso, Simona, Spasiano, Anna, Guerzoni, Maria Elena, Beneitez-Pastor, David, Dedeken, Laurence, Pepe, Alessia, Rosso, Rosamaria, Kunz, Joachim B., de Montalembert, Mariane, Campisi, Saveria, Glenthøj, Andreas, Gonzalez Urdiales, Paula, Benghiat, Fleur Samantha, Azerad, Marie-Agnès, Saunders, Christopher J., Ferreira Faria, Teresa, Casini, Tommaso, Bagnato, Sabrina, Van de Velde, Ann, Labarque, Veerle, Bertoni, Elisa, Van Damme, An, Diamantidis, Michael D., Russo, Roberta, Stiakaki, Eftichia, Quota, Alessandra, Christou, Soteroula, Teles, Maria Jose, Lafiatis, Ioannis, Kerkhoffs, Jean-Louis, Argüello Marina, María, Lorite, Mikael, Rodriguez, Alexis, Iolascon, Achille, Taher, Ali T., Colombatti, Raffaella, Roy, Noemi, Mañú Pereira, Maria Del Mar“…Results between similar sized cohorts of RBCD patients vary between each other and those presented here, highlighting the importance of collecting all of these small cohorts together to ensure adequate statistical power so that definitive risk factors (eg. age, genotype, comorbidities) can be reliably identified and used to guide management of patients with these rare disorders in the light of the ongoing pandemic. [Figure: see text] DISCLOSURES: Longo: Bristol Myers Squibb: Honoraria; BlueBird Bio: Honoraria. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
34629“…However, both the reports are an underestimate of the true figures. The pandemic however has now provided an opportunity for cross- sectoral collaboration for suicide prevention rather than restricting suicide prevention to the health sector Symposium Proposal: Digital Phenotyping in Mental Health This symposium explores the emerging field of digital phenotyping in mental health. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
34630por Alam, Muhammad Shahbubul, Song, Dong-Heon, Lee, Jeong-Ah, Hoa, Van-Ba, Kim, Hyoun-Wook, Kang, Sun-Moon, Cho, Soo-Hyun, Hwang, Inho, Seol, Kuk-Hwan“…ABSTRACT: The objectives of this study were to elucidate the effect of different high-concentration levels of inert gases (Ar and N(2)) on heme-pigment solutions and on the color of the blood, meat, and small intestine of rabbits; and to figure out the proper concentration level of inert gas (Ar or N(2)) for the complete stunning of the rabbit. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
34631por Yang, Guang, Zhou, Siyuan, He, Haoqiang, Shen, Zinuo, Liu, Yongmei, Hu, Jun, Wang, Jie“…Finally, the ROC curve was utilized to assess the level and diagnostic efficacy of various molecules (Figure 1).…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
34632por Deb, Suman“…The sensitivity of hadronic resonances to rescattering and regeneration processes in the hadronic phases is depicted in Figure~\ref{fig_hadronic_phase}. The major objectives of this thesis are to understand the interplay of various processes in the hadronic phase with event shape and high-multiplicity dependence study of $\rm{K}^{*\pm}$ meson production using ALICE detectors at the LHC (CERN). …”
Publicado 2022
Enlace del recurso
-
34633por O'Hara, Rosemary, Murphy, Evelyn P, Whitehead, Alexander S, FitzGerald, Oliver, Bresnihan, Barry“…RESULTS: A-SAA mRNA expression was detected using RT-PCR in all eight synovial tissue samples studied. Figure 1 demonstrates RT-PCR products generated using synovial tissue from three representative RA patients. …”
Publicado 2000
Enlace del recurso
Enlace del recurso
Texto -
34634por Reynolds, Megan M., Beagley, Melanie, Fox, Ashley M., Wen, Ming, Varner, Michael W., Smith, Ken R.“…To help convey the meaning of this coefficient, we generated marginal effects of SNAP participation based on SNAP generosity, setting all covariates equal to their means. This figure shows a small negative effect of SNAP participation at the lowest levels of generosity (a score of around 4, the sample minimum). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
34635por Mack, Andrew R, Bethel, Christopher, Marshall, Steven, Patel, Robin, Patel, Robin, van Duin, David, Fowler, Vance G, Rhoads, Daniel D, Jacobs, Michael, van den Akker, Focco, Six, David A, Moeck, Greg, Papp-Wallace, Krisztina M, Bonomo, Robert A“…Taniborbactam is currently undergoing phase 3 clinical trials in combination with cefepime (FEP; Fig 1) as part of the β-lactam-BLI (BL-BLI) combination FEP-taniborbactam (FTB). [Image: see text] Figure 1. Structures of taniborbactam and cefepime. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
34636por Harrington, Patrick, Doores, Katie, Saha, Chandan, Saunders, Jamie, Radia, Deepti H., Kordasti, Shahram, Dillon, Richard, Raj, Kavita, Seow, Jeffrey, Graham, Carl, Lechmere, Thomas, Saglam, Sukran, Child, Fiona, O'Reilly, Amy, Espehana, Andreas, Mehra, Varun, McLornan, Donal P., Malim, Michael, Harrison, Claire N., de Lavallade, Hugues“…We are currently analysing the response to a second vaccine injection and responses to sequential doses of vaccination across the whole cohort will be presented. [Figure: see text] DISCLOSURES: Harrington: Bristol Myers Squibb: Research Funding; Incyte: Honoraria. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
34637“…Right? We’re trying to figure out if a certain treatment is good or not. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
34638por Lazzari, Federico“…The ghost rate in this simulation turned out to be quite high (∼ 50%), but this figure is similar to what obtained with software when using only a portion of the available tracking layers, and does not indicate a problem for the complete system. …”
Publicado 2019
Enlace del recurso
-
34639por Hijjeh, Majed, Al Shaikh, Loua, Alinier, Guillaume, Selwood, David, Malmstrom, Faisal, Hassan, Ibrahim Fawzy“…The CCNW is steered by a multidisciplinary committee (Figure 1) that is empowered with the generative, managerial, and fiscal responsibilities to enable the required changes to take place. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
34640por Wiedmeier, Julia E., Iqbal, Madiha, Munoz, Javier, Bezerra, Evandro D., Garcia Robledo, Juan Esteban, Bansal, Radhika, Johnston, Patrick B., Hathcock, Matthew, Larsen, Jeremy T., Bergsagel, P. Leif, Wang, Yucai, Reeder, Craig B., Leis, Jose F., Fonseca, Rafael, Palmer, Jeanne M., Warsame, Rahma M, Kourelis, Taxiarchis, Hayman, Suzanne R., Dingli, David, Kapoor, Prashant, Kumar, Shaji, Durani, Urshila, Villasboas, Jose C., Paludo, Jonas, Bennani, N. Nora, Ansell, Stephen M., Castro, Januario E, Kharfan-Dabaja, Mohamed A., Lin, Yi, Vergidis, Paschalis, Murthy, Hemant S., Rosenthal, Allison C.“…JEWN, MI and JM are co-first authors and PV, HM and AR are co-senior authors. [Figure: see text] DISCLOSURES: Munoz: Physicians' Education Resource: Honoraria; Seattle Genetics: Honoraria; Bayer: Research Funding; Gilead/Kite Pharma: Research Funding; Celgene: Research Funding; Merck: Research Funding; Portola: Research Funding; Incyte: Research Funding; Genentech: Research Funding; Pharmacyclics: Research Funding; Seattle Genetics: Research Funding; Janssen: Research Funding; Millennium: Research Funding; Gilead/Kite Pharma, Kyowa, Bayer, Pharmacyclics/Janssen, Seattle Genetics, Acrotech/Aurobindo, Beigene, Verastem, AstraZeneca, Celgene/BMS, Genentech/Roche.: Speakers Bureau; Pharmacyclics/Abbvie, Bayer, Gilead/Kite Pharma, Pfizer, Janssen, Juno/Celgene, BMS, Kyowa, Alexion, Beigene, Fosunkite, Innovent, Seattle Genetics, Debiopharm, Karyopharm, Genmab, ADC Therapeutics, Epizyme, Beigene, Servier: Consultancy; Targeted Oncology: Honoraria; OncView: Honoraria; Kyowa: Honoraria. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto